Grants for State governments - Federal

This funding opportunity provides financial support for projects that promote the conservation and restoration of native plants and ecosystems on public lands in Wyoming, particularly benefiting underrepresented communities and enhancing biodiversity.

This funding opportunity supports doctoral students from underrepresented backgrounds in mental health research to complete their dissertation projects and advance their careers in the field.

This funding opportunity supports research projects that aim to improve access to and effectiveness of treatment for Alcohol Use Disorder, particularly for underserved populations, by addressing barriers and enhancing care delivery.

The purpose of this NOFO is to solicit applications for Guardrail Safety Training program that will result in the award of one (1) cooperative agreement award and the distribution of up to $500,000.00 in Federal funding over the life of the project. The actual amount available to be awarded under this notice will be subject to the availability of funds. PROGRAM GOALS The goal of Guardrail Safety Training is three-fold:1. To provide technical assistance;2. To develop support materials for training activities; and3. To develop and conduct webinar trainings for roadway agency standards engineers/sections.Through the development of the products outlined in this cooperative agreement the desired outcome is improved guardrail design and installation.ADMINISTRATION GOALSThe FHWA seeks to fund tasks under this NOFO that advance the United States Department of Transportations National Roadway Safety Strategy (NRSS). The NRSS outlines the Departments comprehensive approach to significantly reducing serious injuries and deaths on our Nations highways, roads, and streets. This is the first step in working toward an ambitious long-term goal of reaching zero roadway fatalities.

This program provides funding to local organizations in Arkansas to help reduce poverty and support low-income individuals through services like employment, education, housing, nutrition, and health.

Management, Species, Harbor Porpoise, (RAM#FXSBA53247215-A), Joint Base Elmendorf-Richardson, Alaska - The objectives of this requirement are to (1) determine Harbor Porpoise presence in Knik Arm during the winter and (2) determine the presence of Harbor Porpoise in Knik Arm and the timing and extent of upstream movement of Harbor Porpoise in the Eagle River during summer and fall. See full Funding Opportunity Description in Section I.

The DARPA Defense Sciences Office grant is aimed at fostering scientific discovery and innovation, anticipating future technological advancements, and understanding global changes to maintain a strategic advantage for the Department of Defense.

This funding opportunity supports researchers who have received a specific career development award to conduct small-scale projects that will help them become independent investigators.

The National Park Services (NPS) History of Equal Rights Grant Program (HER) will preserve sites related to the struggle of all Americans to achieve equal rights. HER grants are funded by the Historic Preservation Fund (HPF), administered by the NPS, and will fund a broad range of preservation projects for historic sites including: architectural services, historic structure reports, preservation plans, and physical preservation to structures. Grants are awarded through a competitive process and do not require non-Federal match.

The NIAID Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional), designated as PAR-22-241, is a funding opportunity issued by the NIH's National Institute of Allergy and Infectious Diseases (NIAID). The program targets New Investigators (NI) and At-Risk Investigators from underrepresented backgrounds in the biomedical, clinical, behavioral, and social sciences. New Investigators are those who have not previously secured substantial independent NIH funding, while At-Risk Investigators are those with previous funding but face a lack of funding in the following fiscal year unless a new grant is awarded. This initiative aligns with the goals of the 21st Century Cures Act to encourage new researchers, foster early independence, and support a more diverse scientific workforce. This funding announcement supports research relevant to the NIAID mission, including the study and treatment of infectious, immunologic, and allergic diseases. Research areas of focus include microbiology, immunology, infectious diseases, AIDS, transplantation, and emerging diseases. Although clinical trials are optional, applicants proposing NIH-defined clinical trials must consult with NIAID before submission. The funding opportunity is open to projects that advance diversity in the R01 investigator pool and those promoting representation from underrepresented groups in line with NIH’s interest in enhancing diversity across all health-related fields. To apply, investigators must be affiliated with U.S.-based higher education institutions or eligible nonprofits and for-profit organizations. This opportunity is also open to minority-serving institutions, such as Hispanic-serving Institutions, HBCUs, and Tribally Controlled Colleges and Universities. Non-domestic (non-U.S.) entities are not eligible, although foreign components of U.S. organizations are permitted. An essential part of the application process is an Eligibility Certification Letter from the applicant institution verifying the applicant’s eligibility and alignment with the program’s diversity objectives. Applications missing this letter will be considered incomplete. Funding levels are based on the project’s actual needs and are not capped, with a project duration of up to five years. NIAID also expects applicants to allocate funding in their budgets for mandatory attendance at a workshop designed to foster networking, collaboration, and professional growth among awardees, to be held every three years starting in 2025. Additional support for necessary accommodations for researchers with disabilities may also be included in the budget. The application process requires thorough adherence to NIH’s submission guidelines, which include registrations with SAM, Grants.gov, eRA Commons, and the acquisition of a UEI. Applications are accepted electronically through the NIH ASSIST system, Grants.gov Workspace, or a system-to-system solution. The next deadline cycle follows NIH’s standard due dates, with submissions due at 5:00 PM local time. Applicants are advised to submit early to address potential errors before the due date. Applications will be evaluated on scientific merit and alignment with program priorities, using criteria focused on the significance of the research, investigator qualifications, project innovation, approach, and institutional environment. Specific review criteria for clinical trials include the adequacy of study design, data management, and statistical analysis plans. Following peer review, recommended applications will receive secondary review by the NIAID advisory council. Final award decisions consider both scientific merit and relevance to NIAID’s mission and diversity goals.

This funding opportunity supports researchers in developing innovative theories and methods to better understand the complex genetic and non-genetic factors influencing human traits and health, with a focus on interdisciplinary approaches and diverse perspectives.

The purpose of this program is to address the public health crisis caused by escalating opioid misuse, opioid use disorder (OUD), and opioid-related overdose across the nation. States and territories are expected to use the resources to: (1) increase access to U.S. Food and Drug Administration (FDA)-approved medications for the treatment of opioid use disorder (MOUD); (2) support the continuum of prevention, harm reduction, treatment, and recovery support services for OUD and other concurrent substance use disorders; and (3) support the continuum of care for stimulant misuse and use disorders, including those involving cocaine and methamphetamine.

This funding opportunity provides support for mid-career and senior researchers to gain new skills and knowledge in dental, oral, and craniofacial research by collaborating with experts in different scientific fields.

The Small Business Act (Act) provides for entrepreneurial training, business development assistance, counseling, and management assistance to small businesses owned and controlled by eligible veterans. Additionally, SBA is authorized to make grants and enter into contracts and cooperative agreements for the establishment and implementation of outreach programs to serve the veteran community.

This grant provides funding to various organizations and governments in New Mexico to support the conservation and restoration of native plant species and habitats, particularly for sensitive ecosystems and underrepresented communities.

This funding opportunity supports nonprofit organizations and educational institutions in creating public exhibitions and programs that explore key themes of American history and culture, engaging diverse audiences through humanities scholarship.

This funding opportunity provides financial support to a wide range of organizations for improving public health surveillance and treatment practices for inherited bleeding disorders, ultimately aiming to enhance health outcomes for affected individuals.

The purpose of the Delta Health Systems Implementation Program (DSIP) is to improve healthcare delivery in rural areas by implementing projects that will improve the financial sustainability of hospitals and allow for increased access to care in rural communities. These projects focus on financial and operational improvement, quality improvement, telehealth, and workforce development in hospitals in the in the rural counties and parishes of the Delta region. This program supports HRSA's collaboration with the Delta Regional Authority.

The DoD Reconstructive Transplant, Qualitative Research Validation and Implementation Award aims to fund further research and development of resources for the Vascularized Composite Allograft (VCA) community, which were initially created through RTRP-funded qualitative research studies, to enhance their readiness for clinical and community use, with a focus on improving patient outcomes and benefiting population health.

This funding opportunity supports U.S. institutions and organizations in developing centers that integrate advanced translational science into cancer clinical trials, enhancing research on precision medicine and rare cancers.